Advertisement
Advertisement

IKNA

IKNA logo

Ikena Oncology Inc

1.57
USD
-0.04
-2.48%
Dec 20, 15:58 UTC -5
Closed
...

Ikena Oncology Inc Profile

About

Ikena Oncology Inc. is focused on developing cancer therapies targeting key signaling pathways which drive the formation and spread of cancer. The company's product candidates include IK-930, IK-175, IK-412 and IK-007, which are in clinical stage. Ikena Oncology Inc. is based in Boston, United States.

Info & Links

CEO

Mark Manfredi

Headquarters

645 SUMMER STREET, SUITE 101
BOSTON, MA 02210, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

61

Employees

43

Ikena Oncology Inc Statistics

Valuation Measures

Market Capitalization2

75.77M

Enterprise Value

30.58M

Enterprise Value/EBITDA(ttm)

-0.44

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.58

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-740.46%

Return on Equity(ttm)

-36.88%

Return on Invested Capital(ttm)

-39.11%

Return on Assets(ttm)

-33.08%

Income Statement

Revenue(ttm)

658.00K

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

658.00K

EBITDA(ttm)3

-69.16M

Net Income Available to Common(ttm)

-59.60M

Diluted EPS(ttm)

-1.23

Share Statistics

Beta (5Y Monthly)

0.49

52-Week Change

2.61%

S&P 500 52-Week Change

24.21%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

48.26M

Dividend Yield

0.00%

Float4

45.39M

% Held by Insiders

5.94%

% Held by Institutions

75.00%

Balance Sheet

Total Cash(mrq)

138.03M

Total Cash Per Share(mrq)

2.86

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

15.32%

Quick Ratio(mrq)

15.32%

Book Value Per Share(mrq)

2.78

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.82

Free Cash Flow(ytd)

-39.31M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement